2004
DOI: 10.1016/s0883-5403(04)00517-0
|View full text |Cite
|
Sign up to set email alerts
|

An American experience with metal-on-metal total hip arthroplasties*1A 7-year follow-up study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 0 publications
1
19
0
Order By: Relevance
“…The current generation of metal-on-metal (MOM) cobaltchromium-molybdenum bearings in hip arthroplasty have shown overall survivorship rates at 5 and 10 years of 98% and 94% [3,4,13,18,31] respectively. However, reports have emerged describing the presence of periprosthetic soft tissue lesions, which have been described interchangeably as adverse local tissue reactions (ALTR) [1], adverse reactions to metal debris (ARMD) [17], aseptic lymphocytic vasculitis-associated lesions (ALVAL) [33], metallosis [23], and pseudotumors [24].…”
Section: Introductionmentioning
confidence: 99%
“…The current generation of metal-on-metal (MOM) cobaltchromium-molybdenum bearings in hip arthroplasty have shown overall survivorship rates at 5 and 10 years of 98% and 94% [3,4,13,18,31] respectively. However, reports have emerged describing the presence of periprosthetic soft tissue lesions, which have been described interchangeably as adverse local tissue reactions (ALTR) [1], adverse reactions to metal debris (ARMD) [17], aseptic lymphocytic vasculitis-associated lesions (ALVAL) [33], metallosis [23], and pseudotumors [24].…”
Section: Introductionmentioning
confidence: 99%
“…Metal-on-metal articulation for THA has been one subject of research for us [5,9,12,19,23]. Our only repeatable complication with this articulation was dislocation (using 28-and 32-mm heads), so the large-diameter head was attractive [5,12,19].…”
Section: Introductionmentioning
confidence: 99%
“…The component was CE-marked in 1995 and FDA-cleared in 1998. In the general population, cementless fixation of Metasullayered acetabular components was achieved with various component configurations [11,35,45]. Other MoM combinations, with low carbon CoCr alloys, demonstrated poor wear properties [46].…”
Section: Discussionmentioning
confidence: 99%